ze:ro Praxen MVZ fuer Nierenerkrankungen und Bluthochdruck GmbH Mannheim

At ze:ro Praxen MVZ fuer Nierenerkrankungen und Bluthochdruck GmbH Mannheim, clinical research is centered on cardiovascular diseases, with studies focused on common and high-risk conditions such as atherosclerotic cardiovascular disease, elevated lipoprotein(a), and heart failure. The trials are mainly designed to test new treatment options and to better understand how to reduce serious heart and vessel complications.

• Research on lowering lipoprotein(a) to slow the progression of calcific aortic valve stenosis
• Studies aimed at reducing major cardiovascular events in people with established cardiovascular disease
• Trials evaluating approaches for heart failure, including people with preserved or mildly reduced ejection fraction and obesity
• Research in type 2 diabetes, hypertension, and cardiovascular risk to improve prevention of heart-related complications

Overall, the site is contributing to research that seeks to improve treatment effectiveness, lower the risk of myocardial infarction and stroke, and support better long-term care for patients with complex cardiometabolic conditions.